To illustrate the role of APP, PSEN1, and PSEN2 in AD endophenotypes, we conducted AAO, MMSE, MoCA, CDR, and cerebrospinal fluid (CSF) biomarkers association studies in AD patients. This evidence concerns the gene APP and Alzheimer disease.